Rodney Parsons
Executive Director
Rodney Parsons is currently chair of our Mutagenic Impurity Assessment Committee which address all mutagenic impurities including nitrosamine impurities. He is an organic chemist by training and am responsible for the Chemical Technologies group with Chemical Process Development.
December 4, 2024
We are planning to hold an online meeting with subject matter experts to evaluate different points of view on how to solve the problems associated with mutagenic impurities.
Upcoming
DAY 1: December 4th, 2024
SESSION: Addressing NDSRI Risks
◆ Recent HA focus on NDSRI risk has required us to reassess the end to end portfolio to address any concerns from the nitrosamine impurities.
Share This Speaker
